Trial-centrism in the Declaration of Helsinki: A Challenge for Post-Study Access and Preventing Data Colonialism in AI-Driven Health Research

Authors

  • Hazar Haidar Ethics Programs, Department of Letters and Humanities, University of Quebec at Rimouski, Rimouski, Quebec, Canada https://orcid.org/0000-0001-5005-0012
  • Ehsan Shamsi Gooshki Monash Bioethics Centre, Monash University, Melbourne, Victoria, Australia; Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.7202/1114971ar

Keywords:

Declaration of Helsinki, post-study access, data colonialism, AI, health research

Language(s):

English

Abstract

This letter proposes extending the post-trial provisions of the updated Declaration of Helsinki beyond pharmaceutical drugs to include AI tools, particularly those developed using data from low- and middle-income countries. Such an extension would help prevent data colonialism and ensure more equitable access to these tools, fostering fairness in global health research.

Downloads

Published

2024-12-02

How to Cite

[1]
Haidar H, Gooshki ES. Trial-centrism in the Declaration of Helsinki: A Challenge for Post-Study Access and Preventing Data Colonialism in AI-Driven Health Research. Can. J. Bioeth 2024;7:138-9. https://doi.org/10.7202/1114971ar.

Issue

Section

Letter to the Editor